bioAffinity Technologies (BIAF) Share-based Compensation (2021 - 2026)
bioAffinity Technologies (BIAF) posted quarterly Share-based Compensation of $13266.0 for Q1 2026, down 95.94% year-over-year from $326616.0 in Q1 2025, and down 79.94% quarter-over-quarter from $66119.0 in Q4 2025.
bioAffinity Technologies (BIAF) Share-based Compensation (2021 - 2026) Analysis & Trends
bioAffinity Technologies (BIAF) has reported Share-based Compensation for 6 consecutive years, with $13266.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Share-based Compensation fell 95.94% year-over-year to $13266.0; the TTM figure through Mar 2026 stood at $617608.0 (down 40.25% YoY), while the FY2025 annual figure was $671474.0, down 32.15% from the prior year.
- Share-based Compensation declined to $13266.0 in Q1 2026 per BIAF's latest filing, from $66119.0 in the prior quarter.
- Across five years, Share-based Compensation topped out at $326616.0 in Q1 2025 and bottomed at $13266.0 in Q1 2026.
- Historically, Share-based Compensation has averaged $162794.0 across 5 years, with a median of $177971.0 in 2023.
- Annual changes were most pronounced in 2023 — Share-based Compensation soared 538.02% — and 2026, when it slumped 95.94%.
- bioAffinity Technologies' Share-based Compensation stood at $36847.0 in 2022, then soared by 536.44% to $234510.0 in 2023, then fell by 0.18% to $234087.0 in 2024, then tumbled by 71.75% to $66119.0 in 2025, then sank by 79.94% to $13266.0 in 2026.
- Business Quant data shows BIAF's Share-based Compensation at $13266.0 in Q1 2026, $66119.0 in Q4 2025, and $211607.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 82.00 Mn |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 93.00 Mn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 16.09 Mn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 2.00 Mn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 95.00 Mn |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 774,000.00 |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 73.00 Mn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 5.37 Mn |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 6.00 Mn |
| 10 | bioAffinity Technologies | 2.38 Mn | -721,990.64 | - | 13,266.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13,266.00 |
| Mar 31, 2026 | 13,266.00 |
| Dec 31, 2025 | 66,119.00 |
| Dec 31, 2025 | 66,119.00 |
| Jun 30, 2025 | 211,607.00 |
| Jun 30, 2025 | 211,607.00 |
| Mar 31, 2025 | 326,616.00 |
| Mar 31, 2025 | 326,616.00 |
| Dec 31, 2024 | 234,087.00 |
| Dec 31, 2024 | 234,087.00 |
| Sep 30, 2024 | 185,687.00 |
| Sep 30, 2024 | 185,687.00 |
| Jun 30, 2024 | 287,294.00 |
| Jun 30, 2024 | 287,294.00 |
| Mar 31, 2024 | 282,613.00 |
| Mar 31, 2024 | 282,613.00 |
| Dec 31, 2023 | 234,510.00 |
| Dec 31, 2023 | 234,510.00 |
| Sep 30, 2023 | 186,445.00 |
| Sep 30, 2023 | 186,445.00 |